KEAP1 and chronic kidney disease: The evidence acquired from the results of immunohistochemical staining, Western blot, and qRT-PCR assay proved that the JPYS formula reversed the decreased expression of Nrf2 and its target gene so-called HO-1 in CKD rats and the increased level of Keap1 (Figures 6A–I).